Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Accelerating the search for new TB drugs – he who shares wins

In 2010, TB killed nearly 1. 4 million people worldwide. But despite the disease's prevalence and the ineffective nature of the current treatment regime for TB, only one new drug candidate has been submitted for approval in the US in the last 40 years. Elly Earls meets Dr Carl Nathan, part of the TB Drug Accelerator project, to find out how seven pharmaceutical companies and four research institutions have joined forces to make sure the next 40 years are significantly more productive – and not just for TB.

Go Top